HLS Therapeutics (HLS) Competitors C$4.41 +0.05 (+1.15%) As of 03:11 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock HLS vs. ACB, WEED, FIRE, EPI, ICC, RIV, CPH, LEAF, OGI, and RXShould you be buying HLS Therapeutics stock or one of its competitors? The main competitors of HLS Therapeutics include Aurora Cannabis (ACB), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), RIV Capital (RIV), Cipher Pharmaceuticals (CPH), Leaf Mobile (LEAF), Organigram (OGI), and BioSyent (RX). These companies are all part of the "drug manufacturers - specialty & generic" industry. HLS Therapeutics vs. Aurora Cannabis Canopy Growth Supreme Cannabis ESSA Pharma ICC Labs RIV Capital Cipher Pharmaceuticals Leaf Mobile Organigram BioSyent Aurora Cannabis (TSE:ACB) and HLS Therapeutics (TSE:HLS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends. Which has more volatility and risk, ACB or HLS? Aurora Cannabis has a beta of 2.71, suggesting that its stock price is 171% more volatile than the S&P 500. Comparatively, HLS Therapeutics has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Does the MarketBeat Community believe in ACB or HLS? Aurora Cannabis received 497 more outperform votes than HLS Therapeutics when rated by MarketBeat users. However, 64.15% of users gave HLS Therapeutics an outperform vote while only 63.14% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformAurora CannabisOutperform Votes53163.14% Underperform Votes31036.86% HLS TherapeuticsOutperform Votes3464.15% Underperform Votes1935.85% Which has stronger earnings and valuation, ACB or HLS? HLS Therapeutics has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than HLS Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora CannabisC$195.83M1.87-C$44.16M-C$0.81-8.27HLS TherapeuticsC$40.13M2.44-C$15.53M-C$1.00-4.42 Do institutionals and insiders believe in ACB or HLS? 13.4% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 65.2% of HLS Therapeutics shares are owned by institutional investors. 0.4% of HLS Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is ACB or HLS more profitable? Aurora Cannabis has a net margin of -22.55% compared to HLS Therapeutics' net margin of -38.70%. Aurora Cannabis' return on equity of -8.36% beat HLS Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-22.55% -8.36% -1.87% HLS Therapeutics -38.70%-25.27%-2.89% Do analysts prefer ACB or HLS? Aurora Cannabis currently has a consensus price target of C$8.75, indicating a potential upside of 30.60%. HLS Therapeutics has a consensus price target of C$4.50, indicating a potential upside of 2.04%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, equities research analysts clearly believe Aurora Cannabis is more favorable than HLS Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 3.33HLS Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media favor ACB or HLS? In the previous week, Aurora Cannabis' average media sentiment score of 0.00 equaled HLS Therapeutics'average media sentiment score. Company Overall Sentiment Aurora Cannabis Neutral HLS Therapeutics Neutral SummaryAurora Cannabis beats HLS Therapeutics on 10 of the 16 factors compared between the two stocks. Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLS vs. The Competition Export to ExcelMetricHLS TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$98.11MC$2.18BC$5.55BC$5.71BDividend Yield4.30%2.92%5.09%6.84%P/E Ratio-4.423.9722.7328.78Price / Sales2.44496.32406.97570.45Price / Cash15.2210.2538.1883.20Price / Book1.755.526.813.76Net Income-C$15.53MC$20.70BC$3.22BC$301.04M7 Day Performance4.26%0.95%2.40%0.96%1 Month Performance-4.13%1.52%3.77%0.17%1 Year Performance-5.16%96.71%16.96%14.72% HLS Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLSHLS TherapeuticsN/AC$4.41+1.1%C$4.50+2.0%-6.2%C$98.11MC$40.13M-4.4291ACBAurora Cannabis1.7016 of 5 starsC$5.90+1.5%C$8.75+48.3%-35.0%C$322.78MC$195.83M-7.291,073WEEDCanopy Growth1.3442 of 5 starsC$1.65+13.0%C$5.64+241.7%-87.7%C$265.43MC$519.68M-0.242,700FIRESupreme CannabisN/AN/AN/AN/AC$259.40MC$53.29M-10.97400EPIESSA PharmaN/AC$8.20+7.2%N/A+0.0%C$237.87MN/A-8.2725ICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533,684.0095.29N/AGap UpRIVRIV CapitalN/AN/AN/AN/AC$213.65MC$11.33M-1.6312CPHCipher Pharmaceuticals0.6193 of 5 starsC$11.11flatC$14.75+32.8%+64.1%C$199.46MC$19.03M12.275Gap UpLEAFLeaf MobileN/AN/AN/AN/AC$198.42MC$83.74M58.86150OGIOrganigram2.9536 of 5 starsC$1.46+5.0%C$3.67+151.1%-40.2%C$180.37MC$180.58M-3.09987News CoverageRXBioSyentN/AC$10.29+0.3%N/A+24.3%C$117.69MC$34.06M16.70N/A Related Companies and Tools Related Companies Aurora Cannabis Competitors Canopy Growth Competitors Supreme Cannabis Competitors ESSA Pharma Competitors ICC Labs Competitors RIV Capital Competitors Cipher Pharmaceuticals Competitors Leaf Mobile Competitors Organigram Competitors BioSyent Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:HLS) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HLS Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HLS Stock Free HLS Stock Alerts